INK1117: A potent and orally efficacious PI3Kα-selective inhibitor for the treatment of cancer

被引：5

作者：

Jessen, Katayoun A. ^{[1
]}

Kessler, Linda ^{[1
]}

Kucharski, Jeff ^{[1
]}

Guo, Xin ^{[1
]}

Staunton, Jocelyn ^{[1
]}

Elia, Marikka ^{[1
]}

Janes, Matthew ^{[1
]}

Lan, Lucy ^{[1
]}

Wang, Shunyou ^{[1
]}

Stewart, Josh ^{[1
]}

Darjania, Levan ^{[1
]}

Li, Liansheng ^{[1
]}

Chan, Katrina ^{[1
]}

Martin, Michael ^{[1
]}

Ren, Pingda ^{[1
]}

Fruman, David ^{[2
]}

Rommel, Christian ^{[1
]}

Liu, Yi ^{[1
]}

机构：

[1] Intellikine, La Jolla, CA USA

[2] UC Irvine, Irvine, CA USA

来源：

CANCER RESEARCH | 2011年 / 71卷

关键词：

D O I：

10.1158/1538-7445.AM2011-4501

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4501

引用

页数：1

共 50 条

[31] Structure-based optimization leads to the discovery of NSC765844, a highly potent, less toxic and orally efficacious dual PI3K/mTOR inhibitor
Han, Jinsong
Chen, Ying
Yang, Chao
Liu, Ting
Wang, Mingping
Xu, Haojie
Zhang, Ling
Zheng, Canhui
Song, Yunlong
Zhu, Ju
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 122 : 684 - 701
[32] Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer
Dorsey, Bruce D.
Iqbal, Mohamed
Chatterjee, Sankar
Menta, Ernesto
Bernardini, Raffaella
Bernareggi, Alberto
Cassara, Paolo G.
D'Arasmo, Germano
Ferretti, Edmondo
De Munari, Sergio
Oliva, Ambrogio
Pezzoni, Gabriella
Allievi, Cecilia
Strepponi, Ivan
Ruggeri, Bruce
Ator, Mark A.
Williams, Michael
MallamoT, John P.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 1068 - 1072
[33] Characterization of selective and potent PI3Kδ inhibitor (PI3KD-IN-015) for B-Cell malignances
Liu, Xiaochuan
Wang, Aoli
Liang, Xiaofei
Chen, Cheng
Liu, Juanjuan
Zhao, Zheng
Wu, Hong
Deng, Yuanxin
Wang, Li
Wang, Beilei
Wu, Jiaxin
Liu, Feiyang
Fernandes, Stacey M.
Adamia, Sophia
Stone, Richard M.
Galinsky, Ilene A.
Brown, Jennifer R.
Griffin, James D.
Zhang, Shanchun
Loh, Teckpeng
Zhang, Xin
Wang, Wenchao
Weisberg, Ellen L.
Liu, Jing
Liu, Qingsong
[J]. ONCOTARGET, 2016, 7 (22) : 32641 - 32651
[34] Discovery of a potent and highly selective, orally efficacious IKK2 inhibitor for the treatment of rheumatoid arthritis
Liddle, John
Williamson, Rick A.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[35] Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα
Nacht, Mariana
Qiao, Lixin
Sheets, Michael P.
St. Martin, Thia
Labenski, Matthew
Mazdiyasni, Hormoz
Karp, Russell
Zhu, Zhendong
Chaturvedi, Prasoon
Bhavsar, Deepa
Niu, Deqiang
Westlin, William
Petter, Russell C.
Medikonda, Aravind Prasad
Singh, Juswinder
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (03) : 712 - 721
[36] PKI-179: An orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor
Venkatesan, Aranapakam M.
Chen, Zecheng
Dos Santos, Osvaldo
Dehnhardt, Christoph
Delos Santos, Efren
Ayral-Kaloustian, Semiramis
Mallon, Robert
Hollander, Irwin
Feldberg, Larry
Lucas, Judy
Yu, Ker
Chaudhary, Inder
Mansour, Tarek S.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) : 5869 - 5873
[37] Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR
Martinez Gonzalez, Sonia
Isabel Hernandez, Ana
Varela, Carmen
Lorenzo, Milagros
Ramos-Lima, Francisco
Cendon, Elena
Cebrian, David
Aguirre, Enara
Gomez-Casero, Elena
Albarran, M. I.
Alfonso, Patricia
Garcia-Serelde, Beatriz
Mateos, Genoveva
Oyarzabal, Julen
Rabal, Obdulia
Mulero, Francisca
Gonzalez-Granda, Teresa
Link, Wolfgang
Fominaya, Jesus
Barbacid, Mariano
Bischoff, James R.
Pizcueta, Pilar
Blanco-Aparicio, Carmen
Pastor, Joaquin
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (16) : 5208 - 5214
[38] First PI3K Inhibitor for Breast Cancer
Voelker, Rebecca
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (01): : 19 - 19
[39] Synthesis and screening of PI3K inhibitor prodrugs for prostate cancer treatment
Pinder, Tanya A.
Welker, Mark
Kulik, George
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[40] Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTOR
Yu, Tao
Li, Ning
Wu, Chengde
Guan, Amy
Li, Yi
Peng, Zhengang
He, Miao
Li, Jie
Gong, Zhen
Huang, Lei
Gao, Bo
Hao, Dongling
Sun, Jikui
Pan, Yan
Shen, Liang
Chan, Chichung
Lu, Xiulian
Yuan, Hongyu
Li, Yongguo
Li, Jian
Chen, Shuhui
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (03): : 256 - 261

← 1 2 3 4 5 →